1. Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
   Shuanghe Li et al, 2022, Journal of Clinical Medicine CrossRef
2. Safety of PARP inhibitors as maintenance therapy in ovarian cancer
   Sabrina Chiara Cecere et al, 2023, Expert Opinion on Drug Safety CrossRef
3. Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data
   Michael Friedlander et al, 2023, American Society of Clinical Oncology Educational Book CrossRef
4. Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC)
   Walaa Bayoumie El Gazzar et al, 2023, Journal of Oncology Pharmacy Practice CrossRef